“In Silico Investigation of DLBS3233 Bioactives Targeting Inflammatory, Metabolic, and Cholesterol Transport Pathways in Gallstone (Cholelithiasis) Pathogenesis” (2026) Nutrición Clínica y Dietética Hospitalaria, 46(1). doi:10.12873/461baulia.